Hubungan antara Leukosit dengan Procalcitonin sebagai Biomarker Sepsis di Rumah Sakit Umum Pusat Haji Adam Malik Bulan Agustus – Oktober 2015 Medan
34
DAFTAR PUSTAKA
American College of Chest Physicians/Society of Critical Care Medicine
Consensus Conference: Definitions for Sepsis and Organ Failure and
Guidelines for The Use of Innovative Therapies in Sepsis. Critical Care
Medicine, 1992. Vol 20 no 6.
Appelmelk Bj, Lynn WA.2000.The Cause of Sepsis: Bacterial Cell Component
That Trigger the Cytokine Cascade. In: Dhainaut JF, Thijs L, Park G,
Editors, Septic Shock. London. WB Saunders Co. pg. 21-39.
Balci C, Sungurtekin H, Gurses E, et al.2003. Usefulness of Procalcitonin for
Diagnosis of Sepsis in The Intensive Care Unit. Critical Care.pg.85-90.
Bloch KC. Infectious Diseases In : Mc Phee SJ, Ganong WF. Pathophysiology of
Disease. Fifth Edition. New York.2000. P:83-84.
Buchori, Prihatini.2006. Diagnosis Sepsis menggunakan Procalcitonin.Indonesian
Journal of Clinical Pathology and Medical Laboratory, Vol.12, No.3, Juli:
pg.131-7.
Chen, K., and Pohan, H.T., 2009. Penatalaksanaan Syok Septik. In: Sudoyo, A.W.,
Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S., ed. Buku Ajar Ilmu
Penyakit Dalam. 5th ed. Jakarta: Interna Publishing, 252-256.
Cheng, Baoli, et al. 2007."Epidemiology of severe sepsis in critically ill surgical
patients in ten university hospitals in China." Critical care medicine
35.11 : pg. 2538-2546.
Dasenbrook, E., and Merlo, C., 2008. Critical Care. In: Le, T., Hong, P.C., and
Baudendistel, T.E., ed. First Aid for The Internal Medicine Boards. 2nd ed.
USA: Mc Graw Hill,pg. 157-159.
Delevaux I, Andre M, Colombier M, et al.2003. Can Procalcitonin Measurement
Help in Differentiating Between Bacterial Infection and Other Kinds of
Inflammatory Processes ?. Ann Rheum Dis.62:pg. 337 – 340.
Universitas Sumatera Utara
35
Dellinger, R. Phillip, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig
Gerlach, Steven M. Opal, Jonathan E. Sevransky et al. 2012. Surviving
Sepsis Campaign: International Guidelines for Management of Severe
Sepsis and Septic Shock.Intensive care medicine 39, no. 2 (2013): 165-228.
Gaba, C., and I. Kushner.2000. Acute-phase proteins and other systemic response
to inflammation.NEJM.340.6: pg.448-454.
Gossman, W.G., and Plantz, S.H., 2008. Pearls of Wisdom Emergency Medicine
Oral Board Review. 5th ed. USA: Mc Graw Hill.
Guntur A H.2007. Sepsis. Dalam : Buku Ajar Ilmu Penyakit Dalam. Sudoyo AW,
Setiyohadi B, Alwi I, dkk (Editor). Jakarta. Pusat Penerbitan Ilmu
Penyakit Dalam FK UI; 2007:1862-5
Guyton, AC. Hall JE. 2007. Buku Ajar Fisiologi Kedokteran.Edisi 11.Jakarta.
EGC.
Hack CE, Thijs L.2000. Role of Inflammatory Mediators in Sepsis. In: Dhainaut
JF Thijs L, Park G, eds. Septic Shock. London.WB Saunders Co. 2000.
Page. 41-127.
Hammer C, Hobel G, Hamme S, et al.2002. Diagnosis and Monitoring of
Inflammatory Events in Transplant Patients.In:Trull Ak, Demers LM, Holt
DW, et al. Biomarkers of Disease An Evidence-Based Approach
Cambridge University Press, Cambridge United Kingdom. pg.474-48.
Henry JB. 2003.High White Blood Cell Counts, In : Clinical Diagnosis And
Management. 19th ed. WB. Saunders. pg. 81
Hinds, Moss, P.J., Langmead, L., Preston, S.L., C.J., Watson, D., Pearse, R.M.,
2012. Kumar and Clark’s Clinical Medicine. 8th ed. Spanyol: Saunders
Elsevier.
Junquera, Carlos L, 2007. Leukosit. Dalam : Histologi Dasar Teks dan Atlas, edisi
10. Jakarta: EGC; 223-230.
Universitas Sumatera Utara
36
Kasper, Braunwald, Fauci, Hauser, Longo, Jameson(Editors). 2005.Sepsis and
Septic Shock. Harrison’s Manual Of Medicine. 16 th Edition, Mc Graw
Hill. pg.49-53.
Kosanke R, Beier W, Lipecky R, Meisner M. 2008. Clinical Benefits of
Procalcitonin. Tannafos. 7:pg.14 – 18.
LaRosa, S.P., 2010. Sepsis. Dalam: Gordon, S., ed. Current Clinical Medicine.
2nd ed. Philadelphia: Saunders Elsevier, pg.720-725.
M. Sopiyudin Dahlan.2015. Statistik untuk kedokteran dan kesehatan. 6th ed.
Jakarta: Salemba Medika.pg. 224
Meisner M, Brunkhorst FM, Reith H, Schmidt J, et al. 2000.Clinical Experiences
with a New Semi-Quantitative Solid Phase Immunoassay for Rapid
Measurement of Procalcitonin. Clin Chem Lab Med. 38(10): pg. 989-95.
Meisner M, Tschaikowsky K, Schabel S, et al. 1997.PCT - Influence of
Temperature, Storage, Anticoagulation and Arterial or Venous
Asservation Of Blood Samples on Procalcitonin Concentrations. Eur J.
Clin Chem. Clin Biochem,35 (8): pg.597-60.
Meisner M. 2002. Pathobiochemistry and Clinical Use of Procalcitonin. Clinica
Chimica Acta. 323.pg. 17-29.
Meisner M.2005. Biomarkers of Sepsis : Clinically Useful ?. Current Opinion in
Critical Care,11.pg. 473 – 480.
Munford, R.S., 2008. Severe Sepsis and Septic Shock. Dalam: Fauci et al., ed.
Harrison,s Principles of Internal Medicine. 17th ed. USA: Mc Graw Hill,
1695-1702.
Murzalina, Cut.2008. Procalcitonin pada pasien sepsis yang telah mendapat
perawatan di ruang rawat intensif. Tesis. Sumatera Utara: Fakultas
Kedokteran, Universitas Sumatera Utara.
Universitas Sumatera Utara
37
Nasronudin,2007. Perubahan Mediator selama Perjalanan Sepsis. Dalam : SEPSIS.
Penyakit Infeksi di Indonesia. Nasronudin, Hadi Usman, Vitanata, dkk
(Editor). Surabaya.Airlangga University Press;hal. 257-262.
O'Connor E, Venkatesh B, lipman J, et al.2001. Procalcitonin in Critical Illness.
Critical Care and Resuscitation.3.pg. 236-243.
Pohan HT. 2005.Pemeriksaan Procalcitonin untuk Diagnosis Infeksi Berat.
dalam: Pohan HT, Widodo D (editor), Penyakit Infeksi. Jakarta: FKUI;
2004. hal: 32-9.
Purba, Donald Boy P. 2011. Procalcitonin Sebagai Marker dan Hubungannya
dengan Derajat Keparahan Sepsis. Karya Tulis Ilmiah. Sumatera Utara:
Fakultas Kedokteran, Universitas Sumatera Utara.
Raghavan M, Marik PE. 2006.Management of Sepsis During the Early “Golden
Hours”. The Journal of Emergency Medicine, Vol 31, No.2. pp.185-99.
Rau B, Kruger CM, Schilling M K. 2004. Procalcitonin : Improved Biochemical
Severity Stratification and Post Operative Monitoring in Severe
Abdominal Inflammation and Sepsis. Langenbecks Arch Surg;pg. 389:
134-144.
Robert S. Munford, 2008. Harrison’s Internal Medicine, 17th Edition, USA,
McGraw – Hill, page 1695-1699.
Russell, J.A., 2012. Shock Syndromes Related to Sepsis. In: Goldman, L., and
Schaffer, A.I., ed. Goldman’s Cecil Medicine. 24th ed. Philadelphia:
Elsevier Saunders, pg.658-665.
Saadat, S., 2008. Deja Review Internal Medicine. USA: Mc Graw Hill.
Shapiro, N.I., Zimmer, G.D., and Barkin, A.Z., 2010. Sepsis Syndromes. In: Marx
et al., ed. Rosen’s Emergency Medicine Concepts and Clinical Practice.
7th ed. Philadelphia: Mosby Elsevier, pg.1869-1879
Universitas Sumatera Utara
38
Sherwood, Lauralee. 2012. Fisiologi Manusia dari Sel ke Sistem.Edisi 6. Jakarta.
EGC
Simon L, Gauvin F, Amre DK, et al. 2004.Serum Procalcitonin and C-Reaktive
Protein Levels as Marker of Bacterial Infection : A Systematic Review and
Meta-analysis. Clinical Infectious Diseases;39th: pg. 206 – 17.
Sudigdo S, Sofyan I. 2014.Dasar-dasar metodologi penelitian klinis:5th ed.
Jakarta: Sagung Seto.pg. 345.
Suharto, Nasronudin, Kuntaman, 2007. Penyakit Infeksi di Indonesia Solusi Kini
dan Mendatang. Artikel. Surabaya: Airlangga University Press.
Vienna. 2000.Procalcitonin- a New Marker of The Systemic Inflammatory
Response to Infections. Klinik Fur Anasthesiaologie und Intensiv Therapie
J ena, Germany.
Weber, R., and Fontana, A., 2007. Fever. In: Siegenthaler, W., ed. Differential
Diagnosis in Internal Medicine from Symptom to Diagnosis. Stuttgart:
Thieme, pg. 106-203.
Whicher J, Bienvenu J, Monneret G. 2001.Procalcitonin as an Acute Phase
Marker. Ann Clin Biochem; 38: pg. 483-493.
Universitas Sumatera Utara
DAFTAR PUSTAKA
American College of Chest Physicians/Society of Critical Care Medicine
Consensus Conference: Definitions for Sepsis and Organ Failure and
Guidelines for The Use of Innovative Therapies in Sepsis. Critical Care
Medicine, 1992. Vol 20 no 6.
Appelmelk Bj, Lynn WA.2000.The Cause of Sepsis: Bacterial Cell Component
That Trigger the Cytokine Cascade. In: Dhainaut JF, Thijs L, Park G,
Editors, Septic Shock. London. WB Saunders Co. pg. 21-39.
Balci C, Sungurtekin H, Gurses E, et al.2003. Usefulness of Procalcitonin for
Diagnosis of Sepsis in The Intensive Care Unit. Critical Care.pg.85-90.
Bloch KC. Infectious Diseases In : Mc Phee SJ, Ganong WF. Pathophysiology of
Disease. Fifth Edition. New York.2000. P:83-84.
Buchori, Prihatini.2006. Diagnosis Sepsis menggunakan Procalcitonin.Indonesian
Journal of Clinical Pathology and Medical Laboratory, Vol.12, No.3, Juli:
pg.131-7.
Chen, K., and Pohan, H.T., 2009. Penatalaksanaan Syok Septik. In: Sudoyo, A.W.,
Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S., ed. Buku Ajar Ilmu
Penyakit Dalam. 5th ed. Jakarta: Interna Publishing, 252-256.
Cheng, Baoli, et al. 2007."Epidemiology of severe sepsis in critically ill surgical
patients in ten university hospitals in China." Critical care medicine
35.11 : pg. 2538-2546.
Dasenbrook, E., and Merlo, C., 2008. Critical Care. In: Le, T., Hong, P.C., and
Baudendistel, T.E., ed. First Aid for The Internal Medicine Boards. 2nd ed.
USA: Mc Graw Hill,pg. 157-159.
Delevaux I, Andre M, Colombier M, et al.2003. Can Procalcitonin Measurement
Help in Differentiating Between Bacterial Infection and Other Kinds of
Inflammatory Processes ?. Ann Rheum Dis.62:pg. 337 – 340.
Universitas Sumatera Utara
35
Dellinger, R. Phillip, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig
Gerlach, Steven M. Opal, Jonathan E. Sevransky et al. 2012. Surviving
Sepsis Campaign: International Guidelines for Management of Severe
Sepsis and Septic Shock.Intensive care medicine 39, no. 2 (2013): 165-228.
Gaba, C., and I. Kushner.2000. Acute-phase proteins and other systemic response
to inflammation.NEJM.340.6: pg.448-454.
Gossman, W.G., and Plantz, S.H., 2008. Pearls of Wisdom Emergency Medicine
Oral Board Review. 5th ed. USA: Mc Graw Hill.
Guntur A H.2007. Sepsis. Dalam : Buku Ajar Ilmu Penyakit Dalam. Sudoyo AW,
Setiyohadi B, Alwi I, dkk (Editor). Jakarta. Pusat Penerbitan Ilmu
Penyakit Dalam FK UI; 2007:1862-5
Guyton, AC. Hall JE. 2007. Buku Ajar Fisiologi Kedokteran.Edisi 11.Jakarta.
EGC.
Hack CE, Thijs L.2000. Role of Inflammatory Mediators in Sepsis. In: Dhainaut
JF Thijs L, Park G, eds. Septic Shock. London.WB Saunders Co. 2000.
Page. 41-127.
Hammer C, Hobel G, Hamme S, et al.2002. Diagnosis and Monitoring of
Inflammatory Events in Transplant Patients.In:Trull Ak, Demers LM, Holt
DW, et al. Biomarkers of Disease An Evidence-Based Approach
Cambridge University Press, Cambridge United Kingdom. pg.474-48.
Henry JB. 2003.High White Blood Cell Counts, In : Clinical Diagnosis And
Management. 19th ed. WB. Saunders. pg. 81
Hinds, Moss, P.J., Langmead, L., Preston, S.L., C.J., Watson, D., Pearse, R.M.,
2012. Kumar and Clark’s Clinical Medicine. 8th ed. Spanyol: Saunders
Elsevier.
Junquera, Carlos L, 2007. Leukosit. Dalam : Histologi Dasar Teks dan Atlas, edisi
10. Jakarta: EGC; 223-230.
Universitas Sumatera Utara
36
Kasper, Braunwald, Fauci, Hauser, Longo, Jameson(Editors). 2005.Sepsis and
Septic Shock. Harrison’s Manual Of Medicine. 16 th Edition, Mc Graw
Hill. pg.49-53.
Kosanke R, Beier W, Lipecky R, Meisner M. 2008. Clinical Benefits of
Procalcitonin. Tannafos. 7:pg.14 – 18.
LaRosa, S.P., 2010. Sepsis. Dalam: Gordon, S., ed. Current Clinical Medicine.
2nd ed. Philadelphia: Saunders Elsevier, pg.720-725.
M. Sopiyudin Dahlan.2015. Statistik untuk kedokteran dan kesehatan. 6th ed.
Jakarta: Salemba Medika.pg. 224
Meisner M, Brunkhorst FM, Reith H, Schmidt J, et al. 2000.Clinical Experiences
with a New Semi-Quantitative Solid Phase Immunoassay for Rapid
Measurement of Procalcitonin. Clin Chem Lab Med. 38(10): pg. 989-95.
Meisner M, Tschaikowsky K, Schabel S, et al. 1997.PCT - Influence of
Temperature, Storage, Anticoagulation and Arterial or Venous
Asservation Of Blood Samples on Procalcitonin Concentrations. Eur J.
Clin Chem. Clin Biochem,35 (8): pg.597-60.
Meisner M. 2002. Pathobiochemistry and Clinical Use of Procalcitonin. Clinica
Chimica Acta. 323.pg. 17-29.
Meisner M.2005. Biomarkers of Sepsis : Clinically Useful ?. Current Opinion in
Critical Care,11.pg. 473 – 480.
Munford, R.S., 2008. Severe Sepsis and Septic Shock. Dalam: Fauci et al., ed.
Harrison,s Principles of Internal Medicine. 17th ed. USA: Mc Graw Hill,
1695-1702.
Murzalina, Cut.2008. Procalcitonin pada pasien sepsis yang telah mendapat
perawatan di ruang rawat intensif. Tesis. Sumatera Utara: Fakultas
Kedokteran, Universitas Sumatera Utara.
Universitas Sumatera Utara
37
Nasronudin,2007. Perubahan Mediator selama Perjalanan Sepsis. Dalam : SEPSIS.
Penyakit Infeksi di Indonesia. Nasronudin, Hadi Usman, Vitanata, dkk
(Editor). Surabaya.Airlangga University Press;hal. 257-262.
O'Connor E, Venkatesh B, lipman J, et al.2001. Procalcitonin in Critical Illness.
Critical Care and Resuscitation.3.pg. 236-243.
Pohan HT. 2005.Pemeriksaan Procalcitonin untuk Diagnosis Infeksi Berat.
dalam: Pohan HT, Widodo D (editor), Penyakit Infeksi. Jakarta: FKUI;
2004. hal: 32-9.
Purba, Donald Boy P. 2011. Procalcitonin Sebagai Marker dan Hubungannya
dengan Derajat Keparahan Sepsis. Karya Tulis Ilmiah. Sumatera Utara:
Fakultas Kedokteran, Universitas Sumatera Utara.
Raghavan M, Marik PE. 2006.Management of Sepsis During the Early “Golden
Hours”. The Journal of Emergency Medicine, Vol 31, No.2. pp.185-99.
Rau B, Kruger CM, Schilling M K. 2004. Procalcitonin : Improved Biochemical
Severity Stratification and Post Operative Monitoring in Severe
Abdominal Inflammation and Sepsis. Langenbecks Arch Surg;pg. 389:
134-144.
Robert S. Munford, 2008. Harrison’s Internal Medicine, 17th Edition, USA,
McGraw – Hill, page 1695-1699.
Russell, J.A., 2012. Shock Syndromes Related to Sepsis. In: Goldman, L., and
Schaffer, A.I., ed. Goldman’s Cecil Medicine. 24th ed. Philadelphia:
Elsevier Saunders, pg.658-665.
Saadat, S., 2008. Deja Review Internal Medicine. USA: Mc Graw Hill.
Shapiro, N.I., Zimmer, G.D., and Barkin, A.Z., 2010. Sepsis Syndromes. In: Marx
et al., ed. Rosen’s Emergency Medicine Concepts and Clinical Practice.
7th ed. Philadelphia: Mosby Elsevier, pg.1869-1879
Universitas Sumatera Utara
38
Sherwood, Lauralee. 2012. Fisiologi Manusia dari Sel ke Sistem.Edisi 6. Jakarta.
EGC
Simon L, Gauvin F, Amre DK, et al. 2004.Serum Procalcitonin and C-Reaktive
Protein Levels as Marker of Bacterial Infection : A Systematic Review and
Meta-analysis. Clinical Infectious Diseases;39th: pg. 206 – 17.
Sudigdo S, Sofyan I. 2014.Dasar-dasar metodologi penelitian klinis:5th ed.
Jakarta: Sagung Seto.pg. 345.
Suharto, Nasronudin, Kuntaman, 2007. Penyakit Infeksi di Indonesia Solusi Kini
dan Mendatang. Artikel. Surabaya: Airlangga University Press.
Vienna. 2000.Procalcitonin- a New Marker of The Systemic Inflammatory
Response to Infections. Klinik Fur Anasthesiaologie und Intensiv Therapie
J ena, Germany.
Weber, R., and Fontana, A., 2007. Fever. In: Siegenthaler, W., ed. Differential
Diagnosis in Internal Medicine from Symptom to Diagnosis. Stuttgart:
Thieme, pg. 106-203.
Whicher J, Bienvenu J, Monneret G. 2001.Procalcitonin as an Acute Phase
Marker. Ann Clin Biochem; 38: pg. 483-493.
Universitas Sumatera Utara